Nivomab

药品简介

Originator: OPDIVO by Bristol-Myers Squibb · Manufacturer: Beacon pharma. Indication & Dosage: Nivomab (Nivolumab), generic OPDIVO is a prescription medicine used to treat lung cancer, head and neck squamous cell cancer, skin cancer (called melanoma), kidney cancer, classical Hodgkin lymphoma (a type of blood cancer), urothelial carcinoma (bladder cancer), liver cancer, colorectal cancer. Nivomab manufactured by Beacon pharma Ltd. in Bangladesh. Nivolumab has to inject slowly into a vein over 30 to 60 minutes, usually once every 2 to 4 weeks. Side Effects: The most common adverse reactions of Nivolumab are: Diarrhea , fever, fatigue , shortness of breath, decreased appetite, cough, nausea , constipation, rash, stomach/ abdominal pain, mouth/ throat sores, vomiting , unusual weakness, headache , pain in muscles, bones, and joints . The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。